A new study coming from the University of Nottingham suggests CBD could play a therapeutic role against anxiety-related substance abuse disorders. The team of researchers led by behavioral neurologist Dr. Carl Stevenson looked at studies surrounding the impact of CBD on fear and drug memory processes, and found CBD effectively reduced the expression of fear and drug memories. These findings suggest CBD not only could interfere with fear recollection and help those suffering phobias and PTSD, but also prevent relapse in those recovering from substance abuse disorders.
Researchers write, “Converging lines of evidence have established that acute CBD treatment is anxiolytic in both animals and humans...A growing number of preclinical studies also indicate that this drug reduces fear memory expression when given acutely. Importantly, CBD produces an enduring reduction in learned fear expression when given in conjunction with fear memory reconsolidation or extinction by disrupting the former and facilitating the latter. This makes CBD a potential candidate for testing as a pharmacological adjunct to psychological therapies or behavioural interventions used in treating PTSD and phobias.” He adds, “Understanding how cannabidiol regulates emotion and emotional memory processing may eventually lead to its use as a treatment for anxiety-related and substance abuse disorders. The published literature makes CBD a potential candidate for testing as a pharmacological support to psychological therapies or behavioural interventions used in treating post-traumatic stress disorder and phobias,”